Company profile

Robert B. Ford
Incorporated in
Fiscal year end
IRS number

ABT stock data

FINRA relative short interest over last month (20 trading days) ?

Investment data

Data from SEC filings
Securities sold
Number of investors


21 Feb 20
5 Apr 20
31 Dec 20


Company financial data Financial data

Quarter (USD) Dec 19 Sep 19 Jun 19 Mar 19
Revenue 8.31B 8.08B 7.98B 7.54B
Net income 1.05B 960M 1.01B 672M
Diluted EPS 0.59 0.53 0.56 0.38
Net profit margin 12.62% 11.89% 12.61% 8.92%
Operating income 1.39B 1.2B 1.21B 739M
Net change in cash -231M 954M 115M -822M
Cash on hand 3.86B 4.09B 3.14B 3.02B
Cost of revenue 3.43B 3.36B 3.28B 3.16B
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue 31.9B 30.58B 27.39B 20.85B
Net income 3.69B 2.37B 477M 1.4B
Diluted EPS 2.06 1.33 0.27 0.94
Net profit margin 11.56% 7.74% 1.74% 6.71%
Operating income 4.53B 3.65B 1.56B 3.03B
Net change in cash 16M -5.56B -9.21B 13.62B
Cash on hand 3.86B 3.84B 9.41B 18.62B
Cost of revenue 13.23B 12.71B 12.41B 9.09B

Financial data from company earnings reports

Date Owner Security Transaction Code $Price #Shares $Value #Remaining
1 Apr 20 Randel William Woodgrift Common shares without par value Payment of exercise Dispose F 78.91 1,368 107.95K 52,491
1 Apr 20 Christopher J Scoggins Common shares without par value Payment of exercise Dispose F 78.91 1,048 82.7K 40,120
1 Apr 20 Andrew H Lane Common shares without par value Payment of exercise Dispose F 78.91 365 28.8K 65,822
1 Apr 20 Andrew H Lane Common shares without par value Grant Aquire A 0 1,659 0 66,187
31 Mar 20 Jaime Contreras Common shares without par value Payment of exercise Dispose F 79.34 343 27.21K 2,624
31 Mar 20 Jaime Contreras Common shares without par value Grant Aquire A 0 740 0 2,967
31 Mar 20 John G Stratton Stock Equivalent Units Common Shares Grant Aquire A 78.91 399 31.49K 5,069
75.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 2125 1992 +6.7%
Opened positions 239 103 +132.0%
Closed positions 106 86 +23.3%
Increased positions 748 709 +5.5%
Reduced positions 829 871 -4.8%
13F shares
Current Prev Q Change
Total value 114.99B 108.84B +5.6%
Total shares 1.32B 1.3B +1.7%
Total puts 7.02M 6.16M +14.0%
Total calls 7.67M 6.52M +17.7%
Total put/call ratio 0.9 0.9 -3.1%
Largest owners
Shares Value Change
Vanguard 151.78M $13.18B +1.2%
BLK BlackRock 124.73M $10.83B -2.5%
Capital Research Global Investors 113.69M $9.88B +0.5%
STT State Street 73.56M $6.39B +1.3%
Capital International Investors 47.33M $4.11B +2.9%
Wellington Management 38.6M $3.35B -5.1%
Massachusetts Financial Services 30.98M $2.69B -2.9%
NTRS Northern Trust 26.74M $2.32B +1.8%
BAC Bank of America 25.08M $2.18B +27.0%
Geode Capital Management 25M $2.17B +1.3%
Largest transactions
Shares Bought/sold Change
Norges Bank 16.85M +16.85M NEW
Polen Capital Management 8.92M +8.8M +7236.6%
BAC Bank of America 25.08M +5.34M +27.0%
Ensign Peak Advisors 3.87M +3.87M NEW
TFC Truist Financial 3.73M +3.34M +857.4%
BLK BlackRock 124.73M -3.16M -2.5%
N Price T Rowe Associates 5.04M -2.54M -33.5%
GS Goldman Sachs 15.74M +2.39M +17.9%
Wellington Management 38.6M -2.09M -5.1%
Fred Alger Management 3.26M -1.88M -36.5%

Financial report summary

  • The manufacture of many of Abbott’s products is a highly exacting and complex process, and if Abbott or one of its suppliers encounters problems manufacturing products, Abbott’s business could suffer.
Management Discussion
  • The increase in Total Net Sales in 2019 reflects volume growth across all of Abbott’s segments.  The increase in Total Net Sales in 2018 reflects the acquisition of Alere, as well as volume growth across all of Abbott’s segments.  The price declines related to the Medical Devices segment in 2019 and 2018 primarily reflect pricing pressures on drug eluting stents (DES) as a result of market competition in the U.S. and other major markets.
  • A comparison of significant product and product group sales is as follows.  Percent changes are versus the prior year and are based on unrounded numbers.
  • n/m = percent change is not meaningful.
Content analysis ?
8th grade Avg
New words: ADC, Africa, andChief, andDirector, book, Boudreau, CEO, Cephea, Christopher, clip, Dale, darren, ear, Earnhardt, electrical, embedded, EMEA, ENT, Eurozone, ExchangeChicago, facilitation, Financeand, forecasted, frequently, gastrointestinal, GI, Ginascol, grasping, guideline, heartbeat, history, HMO, HR, implicit, Inline, Intersect, intraperiod, irregular, jr, judgement, KumbierDirector, leaky, LiddyDirector, Lisa, lock, Mary, mcdew, mild, Milk, Moreland, NaN, nose, Oligosaccharide, optimize, PFI, Philip, prohibit, pulse, Randel, reagent, Reclassification, reset, ROU, secondary, Simplifying, spread, step, stolen, suggest, suggesting, throat, TIBOR, TMVI, travel, warranted, WhiteChairman, Woodgrift, XR
Removed: accelerating, adjust, American, animal, automatically, BBB, Beneficial, Blaser, calibration, commodity, comprised, convert, declined, delinquent, DICOM, DIPRO, distributed, economy, exercisable, finalized, floating, formalized, Fussell, GAAP, generated, holdback, inflationary, inInternal, Irish, Japanese, knowledge, lapsed, liquid, mail, medicine, monetary, move, official, renamed, replace, revalue, Stephen, swap, Takeda, tangible, temporary, unobservable, vacancy, Venezuela, Venezuelan